ERBB2 and breast carcinoma: The selectivity of the proxTEMA results were confirmed by analyses of EGFR negative CHO-K1 cells, and of normal human fresh-frozen colon tissue expressing very low EGFR levels as well as of breast cancer tissue section characterized as 0+ according to HER2 protein staining (Figure 5C, D and Supplementary Figure S14b, c).